Aims: This was a validation study for D-DISH in our laboratory and was conducted to study
the concordance between fluorescence in situ hybridization (FISH) and D-DISH for …

Context.—Human epidermal growth factor (HER2/neu) gene amplification, a poor prognostic
factor in invasive breast cancer, has shown substantial utility as a predictive marker, with …

Objectives: Human epidermal growth factor receptor 2 (HER2; ERBB2 gene) is of prognostic
and predictive significance in breast carcinoma. Both fluorescence in situ hybridization …

Objectives: To compare the INFORM HER2 bright-field dual in situ hybridization (DISH) DNA
probe cocktail assay with the PathVysion fluorescence in situ hybridization (FISH) assay on …

The most optimal method for assessing HER2 status is still subject to controversy as far as
the type of assay used, the optimal method to perform, and the costs of each assay are …

Hwang C‐C, Pintye M, Chang L‐C, Chen H‐Y, Yeh K‐Y, Chein H‐P, Lee N & Chen J‐R
(2011) Histopathology59, 984–992 Dual‐colour chromogenic in‐situ hybridization is a …

Dual-probe fluorescence in situ hybridization (D-FISH) is a widely accepted method to
determine the gene amplification status of human epidermal growth factor receptor 2 (Her …

Methods: We evaluated HER2 DISH as an alternative to FISH and report our findings from
101 cases. In addition, we correlated HER2 DISH and FISH results with HercepTest and 4B5 …

We performed a multicenter assessment of a new HER2 dual-color chromogenic in situ
hybridization (CISH) test and herein report on concordance of CISH data with fluorescence …

García‐Caballero T, Grabau D, Green AR, Gregory J, Schad A, Kohlwes E, Ellis IO, Watts S
& Mollerup J (2010) Histopathology56, 472–480 Determination of HER2 amplification in …